The LaRoques’ Healthcare Empire: From Lavish Weddings to Legal Battles Over Surprise Billing
A couple’s extravagant lifestyle, funded by a company navigating the complexities of out-of-network medical billing, is facing scrutiny amid allegations of exploiting a federal law designed to protect patients.
Alla Kosova and Scott LaRoque first met in Las Vegas in 2014, a chance encounter orchestrated by a friend.1 Kosova, newly divorced, asked a friend to uncover her a husband, leading to an introduction with entrepreneur Scott LaRoque, who was visiting from Texas.1 Their relationship blossomed, culminating in a five-day destination wedding at Villa Cimbrone in Ravello, Italy, in June 2018.1
Today, the couple’s wealth supports a lavish lifestyle, including a mansion and a private jet.2 This prosperity is largely attributed to their company, HaloMD, which operates in the often-opaque world of healthcare revenue recovery.
Navigating the No Surprises Act and Arbitration
HaloMD assists healthcare providers in navigating the arbitration process established by the No Surprises Act of 2020. This federal law aims to shield patients from unexpected, high medical bills when they receive care from out-of-network providers.2 However, critics argue that companies like HaloMD are exploiting loopholes in the law to maximize profits.
HaloMD has develop into a dominant force in the arbitration process, filing more cases than any other company in the first half of 2025 and generating over $1 billion annually for itself and its clients.2
Legal Challenges and Allegations
Four Blue Cross Blue Shield insurers have filed lawsuits against HaloMD, alleging that the company is rigging the system to secure inflated payouts.2 The LaRoques deny these allegations.
Court filings and internal company documents suggest a pattern of arrangements with healthcare providers designed to share the proceeds of medical services.2 These arrangements have been described by sources as unethical and potentially illegal.
Alla LaRoque is the President and Founder of HALOMD.4
The controversy surrounding HaloMD highlights broader concerns about profit-seeking within the American healthcare system and the challenges of effectively regulating complex financial arrangements.